CIA BRASILEIRA DE DIS- ADR (CBD) Forecast, Price Target & Analyst Ratings
NYSE:CBD • US20440T3005
0.445 USD
-0.01 (-3.05%)
At close: Apr 18, 2024
0.4357 USD
-0.01 (-2.09%)
After Hours: 4/18/2024, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CIA BRASILEIRA DE DIS- ADR (CBD).
Forecast Snapshot
Consensus Price Target
$1.53
+ 244.19% Upside
Next Earnings Forecast
Release DateMay 1, 2024
PeriodQ1 / 2024
EPS Estimate-R$0.23
Revenue Estimate4.983B
ChartMill Buy Consensus
50.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$1.53
Upside
+ 244.19%
From current price of $0.45 to mean target of $1.53, Based on 16 analyst forecasts
Low
$0.64
Median
$1.00
High
$6.48
Price Target Revisions
1 Month
-19.66%
3 Months
-10.73%
Price Target Summary
16 analysts have analysed CBD and the average price target is 1.53 USD. This implies a price increase of 244.19% is expected in the next year compared to the current price of 0.445.
The average price target has been revised downward by 10.73% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
50.00%
CBD was analyzed by 16 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about CBD.
In the previous month the buy percentage consensus was at a similar level.
CBD was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-05-04 | B of A Securities | Upgrade | Underperform -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 1, 2024
PeriodQ1 / 2024
EPS Estimate-R$0.23
Revenue Estimate4.983B
Revenue Q2Q10.83%
EPS Q2Q54.35%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
-0.72%
Revenue (3 Months)
-1.13%
EPS (1 Month)
54.81%
EPS (3 Months)
58.85%
Next Earnings Summary
CBD is expected to report earnings on 5/1/2024. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 4.98B USD.
The next earnings revenue estimate has been revised downward by 1.13% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 16.298B -68.20% | 17.321B 6.28% | 19.25B 11.14% | 21.612B 12.27% | 22.673B 4.91% | 24.109B 6.33% | 27.966B 16.00% | |
| EBITDA YoY % growth | 2.434B -54.12% | 1.834B -24.65% | 1.233B -32.77% | 1.684B 36.58% | 1.877B 11.46% | 2.048B 9.11% | 2.39B 16.70% | |
| EBIT YoY % growth | 317M -88.43% | -68M -121.45% | 97M 242.65% | 502.53M 418.07% | 678.29M 34.98% | 797.06M 17.51% | 1.126B 41.27% | |
| Operating Margin | 1.95% | -0.39% | 0.50% | 2.33% | 2.99% | 3.31% | 4.03% | |
| EPS YoY % growth | N/A -15.54% | -0.35 -117.51% | -4.41 -1,171.43% | -0.72 83.74% | -0.37 48.56% | -0.24 34.25% | N/A |
All data in BRL
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.23 54.35% | -0.20 69.79% | -0.16 93.84% | -0.04 93.35% |
| Revenue Q2Q % growth | 4.983B 10.83% | 5.292B 11.29% | 5.295B 11.66% | 5.88B 11.85% |
| EBITDA Q2Q % growth | 376.7M 53.13% | 405.96M -23.98% | 424.21M -50.33% | 546M -57.81% |
| EBIT Q2Q % growth | 66.597M 295.87% | 88.825M 386.53% | 117.86M 2,846.50% | 234.19M 48.22% |
All data in BRL
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
24.83%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
6.72%
Revenue Next 5 Year
8.97%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
102.85%
EBIT Next 5 Year
76.66%
CIA BRASILEIRA DE DIS- ADR / CBD Forecast FAQ
Can you provide the average price target for CIA BRASILEIRA DE DIS- ADR stock?
16 analysts have analysed CBD and the average price target is 1.53 USD. This implies a price increase of 244.19% is expected in the next year compared to the current price of 0.445.
What is the next earnings date for CBD stock?
CIA BRASILEIRA DE DIS- ADR (CBD) will report earnings on 2024-05-01, after the market close.
Can you provide the consensus estimates for CIA BRASILEIRA DE DIS- ADR next earnings?
The consensus EPS estimate for the next earnings of CIA BRASILEIRA DE DIS- ADR (CBD) is -0.23 USD and the consensus revenue estimate is 4.98B USD.
What is the expected long term growth rate for CIA BRASILEIRA DE DIS- ADR (CBD)?
The expected long term growth rate for CIA BRASILEIRA DE DIS- ADR (CBD) is 6.72%.